APA (7th ed.) Citation

Demestre, M., Herzberg, J., Holtkamp, N., Hagel, C., Reuss, D., Friedrich, R. E., . . . Kurtz, A. (2010). Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model. Journal of neuro-oncology, 98(1), . https://doi.org/10.1007/s11060-009-0049-4

Chicago Style (17th ed.) Citation

Demestre, Maria, et al. "Imatinib Mesylate (Glivec) Inhibits Schwann Cell Viability and Reduces the Size of Human Plexiform Neurofibroma in a Xenograft Model." Journal of Neuro-oncology 98, no. 1 (2010). https://doi.org/10.1007/s11060-009-0049-4.

MLA (9th ed.) Citation

Demestre, Maria, et al. "Imatinib Mesylate (Glivec) Inhibits Schwann Cell Viability and Reduces the Size of Human Plexiform Neurofibroma in a Xenograft Model." Journal of Neuro-oncology, vol. 98, no. 1, 2010, https://doi.org/10.1007/s11060-009-0049-4.